1. Home
  2. GNLN vs KALA Comparison

GNLN vs KALA Comparison

Compare GNLN & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenlane Holdings Inc.

GNLN

Greenlane Holdings Inc.

N/A

Current Price

$0.76

Market Cap

2.1M

ML Signal

N/A

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

N/A

Current Price

$3.04

Market Cap

2.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GNLN
KALA
Founded
2005
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Durable Goods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1M
2.5M
IPO Year
2019
2017

Fundamental Metrics

Financial Performance
Metric
GNLN
KALA
Price
$0.76
$3.04
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
17.5K
★ 164.5K
Earning Date
12-01-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 67.39
EPS
N/A
★ N/A
Revenue
★ $13,275,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.64
$0.07
52 Week High
$139.60
$191.00

Technical Indicators

Market Signals
Indicator
GNLN
KALA
Relative Strength Index (RSI) 27.01 77.25
Support Level N/A $2.07
Resistance Level $3.28 $3.71
Average True Range (ATR) 0.14 0.14
MACD -0.02 0.38
Stochastic Oscillator 18.11 73.26

Price Performance

Historical Comparison
GNLN
KALA

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). It serves specialty retailers, smoke shops, head shops, convenience stores, and consumers. Geographically, it operates in United States, Canada, and Europe. It derives majority revenue from the United States. Its two operating segments are: Wholesale and Distribution, which includes legacy e-commerce and drop-ship operations; and Digital Assets, which includes digital asset treasury activities including acquisition, staking and validator participation related to BERA.

About KALA KALA BIO Inc.

Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: